Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research

Michael B. Dinkins, Guanghu Wang, Erhard Bieberich

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Extracellular vesicles (EVs), particularly exosomes, have emerged in the last 10 years as a new player in the progression of Alzheimer's disease (AD) with high potential for being useful as a diagnostic and treatment tool. Exosomes and other EVs are enriched with the sphingolipid ceramide as well as other more complex glycosphingolipids such as gangliosides. At least a subpopulation of exosomes requires neutral sphingomyelinase activity for their biogenesis and secretion. As ceramide is often elevated in AD, exosome secretion may be affected as well. Here, we review the available data showing that exosomes regulate the aggregation and clearance of amyloid-beta (Aβ) and discuss the differences in data from laboratories regarding Aβ binding, induction of aggregation, and glial clearance. We also summarize available data on the role of exosomes in extracellular tau propagation, AD-related exosomal mRNA/miRNA cargo, and the use of exosomes as biomarker and gene therapy vehicles for diagnosis and potential treatment.

Original languageEnglish (US)
Pages (from-to)757-768
Number of pages12
JournalJournal of Alzheimer's Disease
Volume60
Issue number3
DOIs
StatePublished - Jan 1 2017

Fingerprint

Exosomes
Sphingolipids
Alzheimer Disease
Research
Ceramides
Sphingomyelin Phosphodiesterase
Glycosphingolipids
Gangliosides
Extracellular Vesicles
MicroRNAs
Amyloid
Neuroglia
Genetic Therapy
Biomarkers
Messenger RNA
Therapeutics

Keywords

  • Alzheimers disease
  • amyloid
  • biomarker
  • ceramide
  • exosome
  • miRNA
  • sphingomyelinase
  • tau
  • vesicle

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease : A Decade of Research. / Dinkins, Michael B.; Wang, Guanghu; Bieberich, Erhard.

In: Journal of Alzheimer's Disease, Vol. 60, No. 3, 01.01.2017, p. 757-768.

Research output: Contribution to journalReview article

Dinkins, Michael B. ; Wang, Guanghu ; Bieberich, Erhard. / Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease : A Decade of Research. In: Journal of Alzheimer's Disease. 2017 ; Vol. 60, No. 3. pp. 757-768.
@article{9bee73fc00ee4e9b98560b582f1d3ace,
title = "Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research",
abstract = "Extracellular vesicles (EVs), particularly exosomes, have emerged in the last 10 years as a new player in the progression of Alzheimer's disease (AD) with high potential for being useful as a diagnostic and treatment tool. Exosomes and other EVs are enriched with the sphingolipid ceramide as well as other more complex glycosphingolipids such as gangliosides. At least a subpopulation of exosomes requires neutral sphingomyelinase activity for their biogenesis and secretion. As ceramide is often elevated in AD, exosome secretion may be affected as well. Here, we review the available data showing that exosomes regulate the aggregation and clearance of amyloid-beta (Aβ) and discuss the differences in data from laboratories regarding Aβ binding, induction of aggregation, and glial clearance. We also summarize available data on the role of exosomes in extracellular tau propagation, AD-related exosomal mRNA/miRNA cargo, and the use of exosomes as biomarker and gene therapy vehicles for diagnosis and potential treatment.",
keywords = "Alzheimers disease, amyloid, biomarker, ceramide, exosome, miRNA, sphingomyelinase, tau, vesicle",
author = "Dinkins, {Michael B.} and Guanghu Wang and Erhard Bieberich",
year = "2017",
month = "1",
day = "1",
doi = "10.3233/JAD-160567",
language = "English (US)",
volume = "60",
pages = "757--768",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease

T2 - A Decade of Research

AU - Dinkins, Michael B.

AU - Wang, Guanghu

AU - Bieberich, Erhard

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Extracellular vesicles (EVs), particularly exosomes, have emerged in the last 10 years as a new player in the progression of Alzheimer's disease (AD) with high potential for being useful as a diagnostic and treatment tool. Exosomes and other EVs are enriched with the sphingolipid ceramide as well as other more complex glycosphingolipids such as gangliosides. At least a subpopulation of exosomes requires neutral sphingomyelinase activity for their biogenesis and secretion. As ceramide is often elevated in AD, exosome secretion may be affected as well. Here, we review the available data showing that exosomes regulate the aggregation and clearance of amyloid-beta (Aβ) and discuss the differences in data from laboratories regarding Aβ binding, induction of aggregation, and glial clearance. We also summarize available data on the role of exosomes in extracellular tau propagation, AD-related exosomal mRNA/miRNA cargo, and the use of exosomes as biomarker and gene therapy vehicles for diagnosis and potential treatment.

AB - Extracellular vesicles (EVs), particularly exosomes, have emerged in the last 10 years as a new player in the progression of Alzheimer's disease (AD) with high potential for being useful as a diagnostic and treatment tool. Exosomes and other EVs are enriched with the sphingolipid ceramide as well as other more complex glycosphingolipids such as gangliosides. At least a subpopulation of exosomes requires neutral sphingomyelinase activity for their biogenesis and secretion. As ceramide is often elevated in AD, exosome secretion may be affected as well. Here, we review the available data showing that exosomes regulate the aggregation and clearance of amyloid-beta (Aβ) and discuss the differences in data from laboratories regarding Aβ binding, induction of aggregation, and glial clearance. We also summarize available data on the role of exosomes in extracellular tau propagation, AD-related exosomal mRNA/miRNA cargo, and the use of exosomes as biomarker and gene therapy vehicles for diagnosis and potential treatment.

KW - Alzheimers disease

KW - amyloid

KW - biomarker

KW - ceramide

KW - exosome

KW - miRNA

KW - sphingomyelinase

KW - tau

KW - vesicle

UR - http://www.scopus.com/inward/record.url?scp=85030651890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030651890&partnerID=8YFLogxK

U2 - 10.3233/JAD-160567

DO - 10.3233/JAD-160567

M3 - Review article

C2 - 27662306

AN - SCOPUS:85030651890

VL - 60

SP - 757

EP - 768

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 3

ER -